cortisol and glp 1 glucose response to GLP-1 (7-36)-amide (1 g/kg, iv) glp 1 and cortisol Stronger

Although the study focused on autoimmune patients with diabetes, the findings highlight the potential of GLP-1 receptor agonists in managing cardiovascular risk in the broader autoimmune population

LonghitanoCFinlaySPeacheyISwiftJ-LFayet-MooreFBartleTet al

ACSL4 is highly expressed in OA synovial tissue, while the key antioxidant enzyme GPX4 expression is significantly reduced

These findings suggest that IF may be an effective non-pharmacological intervention for managing RA in this population, potentially addressing both primary disease symptoms and associated metabolic complications

[DOI] [PMC free article] [PubMed] [Google Scholar] 477.Shabbir S, et al

With medical oversight, lifestyle adjustments, and individualized support, patients can achieve and maintain real results